Despite a significant 48.8% objective response rate and breakthrough therapy status, this regulatory shift reverses years of ...
The most striking finding in recent oncological research is the significant gain in survival rates for cancers previously ...
From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...
Large cell carcinoma is aggressive, requiring early detection through imaging and biopsy for optimal treatment outcomes.
Explore the latest HER2-targeted therapies for non-small cell lung cancer, including treatment options and patient-centered decision-making strategies.
A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...
A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...
The TellDx CTC iChip platform enables high-efficiency isolation of intact circulating tumor cells without reliance on cell size or epithelial markers. This unbiased approach is particularly well ...
About 80% of people who have lung cancer have non-small-cell lung cancer. NSCLC usually spreads more slowly than small-cell lung cancers. Both cancers affect the lungs and have similar symptoms, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback